About My Health Careers Internship MedBlogs Contact us

Human Clinical Data on Oral Insulin Presented by Biocon in Rome

by Rajashri on September 9, 2008 at 3:16 PM
Font : A-A+

 Human Clinical Data on Oral Insulin Presented by Biocon in Rome

The results of an ascending dose study with their oral insulin drug (IN-105) were presented by Biocon Limited, India's premier biotechnology company, at the European Association for the Study of Diabetes (EASD) meeting in Rome on September 8.

The study involved dosing Type two diabetes subjects with single doses of 0 mg (placebo), 10 mg, 15 mg, 20 mg and 30 mg tablets of IN-105 in five separate periods before a mixed 600 kcal breakfast.


The outcome measurements were the safety and tolerability of IN-105, as well as the pharmacokinetics and pharmacodynamics of IN-105. The results showed that IN-105 was safe and well tolerated by patients.

Absorption of IN-105 was proportional to the dose administered; a serum average Cmax of 350 milliunits, litre was reached at 30 minutes post dosing at the highest dose of 30 mg. The resulting glucose drops showed linearity with respect to the dose. The two hour postprandial glucose rise over baseline for the 10, 15, 20 and 30 mg doses were 15.3, 24.1, 31.3 and 49.5 mg/dl lower than the corresponding rise for placebo.

There were no symptomatic hypoglycemic events observed at any of the doses. Due to the rapid pharamacokinetics of the drug, there were transient values of hypoglycemia seen soon after the administration of the drug; however these values did not result in any symptoms due to the rapid alleviation of glucose levels due to the meal that followed the drug. C-peptide values were also significantly depressed over all the doses tested, indicating a possibility of beta cell rest in patients dosed with IN-105.

Longer term, six month, studies are being planned in type two diabetic subjects to understand the impact of chronic dosing of IN-105 on postprandial glucose control and glycated haemoglobin.

"The present study shows that IN105 delivers physiologically active insulin orally in concentrations sufficient to decrease post-meal hyperglycemia and to decrease the burden of the meal on endogenous insulin secretion. These data support the feasibility of providing insulin orally to treat postprandial hyperglycemia in diabetic patients" affirmed Dr. Harold E Lebovitz, M.D, FACE, Professor of Medicine, Endocrinology and Diabetes State University of New York Health Science Center at Brooklyn.

"The data presented here show that insulin can be reliably delivered in individuals with type two diabetes via the oral route. Further the administered insulin improved control post meal plasma glucose without causing symptomatic hypoglycemia. Such data support the feasibility of oral insulin delivery as a therapeutic option," said Prof Alan D. Cherrington, Ph.D. Professor of Molecular Physiology and Biophysics, Professor of Medicine, Vanderbilt University.

Source: ANI

News A-Z
News Category
What's New on Medindia
Printed Temperature Sensors help with Continuous Temperature Monitoring
Health Benefits of Giloy
Breast Cancer Awareness Month 2021 - It's time to RISE
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetes - Essentials Gestational diabetes Type 2 Diabetes Diabetes - Foot Care Diabesity Dental Check-Up Diabetes in Pets Diabetes Facts and Figures Insulin Hormone Hypoglycemia (Low Blood Sugar) 

Recommended Reading
A comprehensive article on diabetes - both Type 1 and Type 2 diabetes, including : causes, signs, .....
Diabetic Diet Insulin : Sugar and Foodá
Encyclopedia section of medindia briefly explains about Insulin - Sugar and Food...
Gestational diabetes
The condition is not caused by a lack of insulin, but by the action of hormones produced during ......
Dental Check-Up
It is commonly recommended that you visit the dentist twice a year to clean your teeth and gums and ...
With more than one billion people affected, diabesity is the largest epidemic in the world today. Fo...
Diabetes - Essentials
Diabetes is a metabolic disease caused by insulin deficiency that leads to high blood sugar levels a...
Diabetes - Foot Care
Valuable information on diabetic foot care, treatment and prevention....
Diabetes in Pets
Pets like cats and dogs suffer from diabetes, which is similar to that in humans. It is treated with...
Hypoglycemia (Low Blood Sugar)
Hypoglycemia or low blood sugar often occurs in diabetic patients on insulin treatment. Other condit...
Insulin Hormone
Insulin is a natural hormone that controls our blood sugar. Learn about types of insulin and devices...
Type 2 Diabetes
Globalization and changing lifestyles has made diabetes very common in developing countries so much ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use